Antivert

Product NDC
70199-004
11-digit product format
701990004
Labeler code
70199
Product ID
70199-004_085f1a70-ff63-4c02-ac05-2579fe2ef002
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
meclizine hcl
Dosage form
TABLET
Route
ORAL
Labeler
Casper Pharma LLC
Application
NDA010721
Marketing category
NDA
Marketing start
2020-01-15
Marketing end
0000-00-00
Substance
MECLIZINE HYDROCHLORIDE
Active strength
50 mg/1
Pharmacologic classes
Antiemetic [EPC], Emesis Suppression [PE]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct70199-004DDiscontinued by firm2026-07-31
excluded packagepackage70199-00470199-004-01DDiscontinued by firm2026-07-31
excluded packagepackage70199-00470199-004-99DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N010721-001ANTIVERTMECLIZINE HYDROCHLORIDE50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, RS1982-01-20
N010721-004ANTIVERTMECLIZINE HYDROCHLORIDE25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982
N010721-005ANTIVERTMECLIZINE HYDROCHLORIDE25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, CHEWABLE / ORALRLD, RS, Approved before 1982
N010721-006ANTIVERTMECLIZINE HYDROCHLORIDE12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N010721-001AA
N010721-004AA
N010721-006AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N010721-001ANTIVERT50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, RS1982-01-20a50c72e98297…
2026-08-01 22:54:322026-06N010721-004ANTIVERT25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982a50c72e98297…
2026-08-01 22:54:322026-06N010721-005ANTIVERT25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, CHEWABLE / ORALRLD, RS, Approved before 1982a50c72e98297…
2026-08-01 22:54:322026-06N010721-006ANTIVERT12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALAARLD, Approved before 1982a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N010721-001AA1a50c72e98297…
2026-08-01 22:54:322026-06N010721-004AA1a50c72e98297…
2026-08-01 22:54:322026-06N010721-006AA1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDESt. Mary's Medical Park Pharmacyc6b3f4d8-5fcf-2278-e053-2a95a90ab1392026-06-21Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.d7d31433-8f39-4fe6-b542-1b4410122db72026-06-12Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEBryant Ranch Prepack81e1762b-e012-4c6d-96e6-9a9f27a1880a2026-05-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEREMEDYREPACK INC.21d4a6ee-0a66-45d7-bab9-c5eef399713d2026-05-13Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEREMEDYREPACK INC.d53bf04e-5cfc-4974-9b24-2cce545d1bd02026-04-15Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDENuCare Pharmaceuticals,Inc.c31846b2-d47d-a97b-e053-2a95a90a9bec2026-03-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDENuCare Pharmaceuticals,Inc.beb36d86-9fb7-1f60-e053-2995a90aac132026-03-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEBryant Ranch Prepack112103bc-25e2-42cf-8542-ba1d3392a2c32025-08-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEBryant Ranch Prepack27b6a7e0-a361-4705-9f31-719063a65f222025-08-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDERising Pharma Holdings, Inc.c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bd2025-06-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEAdvanced Rx of Tennessee, LLC2d31ae73-3f09-a77c-e063-6294a90ade9a2025-02-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
MECLIZINE HYDROCHLORIDEMECLIZINE HYDROCHLORIDEDirectRxd27fe828-4fee-3ba9-e053-2995a90ae7b62025-01-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEProficient Rx LP92e8390b-5173-4aa1-906d-35d2c0eaaaf62024-08-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEDirect_Rxe79ecf77-0e0a-d7ef-e053-2a95a90a5adf2024-04-09Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEAsclemed USA, Inc.e6a5df4b-5cbf-4a0c-b38a-f4509c9c17db2024-04-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEProficient Rx LPb91435d1-fb95-4939-8478-84e41f44f7322023-04-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 010721
application number: NDA010721

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70199-004-01EA - Each70199-00444c62ded-2654-4cab-a105-decc2ea5f8f712021-08-05

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70199-004-0170199000401100 TABLET in 1 BOTTLE (70199-004-01) 100 tablet2020-01-150000-00-00NoNoCurrent
70199-004-99701990004991000 TABLET in 1 BOTTLE (70199-004-99) 1000 tablet2020-01-150000-00-00NoNoCurrent